Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Marks

Showing results (51-60 of 223) with videos related to

Pageof 23
Sort By:
The Pediatric Infectious Disease Journal|September 1, 1990
Clinical use of ribavirin in the futureM I Marks, J McBride
Applied Microbiology|January 1, 1970
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological mediaM I Marks, E O'Toole
The Journal of Infectious Diseases|September 1, 1973
Experimental animal model for encephalitis due to herpes simplex virusM I Marks, S Carpenter
Pediatrics|February 1, 1982
Are bacterial screening programs in the hospital worthwhile?A Weber, M I Marks
Antimicrobial Agents and Chemotherapy|December 1, 1975
Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicolM I Marks, G Weinmaster
Canadian Medical Association Journal|September 18, 1976
Letter: Influenza immunization in childrenS Schevill, M I Marks
Drugs|October 1, 1984
Chloramphenicol in the 1980sI Shalit, M I Marks
Canadian Medical Association Journal|February 5, 1977
Adverse reactions to 1975 bivalent influenza vaccine in childrenS Schevill, M I Marks
Clinical Pharmacy|July 1, 1982
Chloramphenicol: recent developments and clinical indicationsM I Marks, C Laferriere
The Journal of Pediatrics|March 1, 1982
Is Clostridium difficile pathogenic in infants?D F Welch, M I Marks
Pageof 23

Showing results (51-60 of 223) with videos related to

Sort By:
Pageof 23
The Pediatric Infectious Disease Journal|September 1, 1990
Clinical use of ribavirin in the futureM I Marks, J McBride
Applied Microbiology|January 1, 1970
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological mediaM I Marks, E O'Toole
The Journal of Infectious Diseases|September 1, 1973
Experimental animal model for encephalitis due to herpes simplex virusM I Marks, S Carpenter
Pediatrics|February 1, 1982
Are bacterial screening programs in the hospital worthwhile?A Weber, M I Marks
Antimicrobial Agents and Chemotherapy|December 1, 1975
Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicolM I Marks, G Weinmaster
Canadian Medical Association Journal|September 18, 1976
Letter: Influenza immunization in childrenS Schevill, M I Marks
Drugs|October 1, 1984
Chloramphenicol in the 1980sI Shalit, M I Marks
Canadian Medical Association Journal|February 5, 1977
Adverse reactions to 1975 bivalent influenza vaccine in childrenS Schevill, M I Marks
Clinical Pharmacy|July 1, 1982
Chloramphenicol: recent developments and clinical indicationsM I Marks, C Laferriere
The Journal of Pediatrics|March 1, 1982
Is Clostridium difficile pathogenic in infants?D F Welch, M I Marks
Pageof 23